Plaintiffs In C8 Litigation: DuPont’s Objection To Case Schedule Is ‘Meritless'
Mealey's (August 10, 2016, 1:19 PM EDT) -- COLUMBUS, Ohio — The Ohio residents who sued E.I. du Pont de Nemours and Co. alleging injuries from exposure to perfluorooctanoic acid (known as C8) on Aug. 8 filed a brief in Ohio federal court, arguing that the company’s objection to a case management order that calls for the acceleration and selection of trial cases is “meritless” (In re E.I. du Pont de Nemours and Co. C8 Personal Injury Litigation, MDL No. 2433, No. 13-2433, S.D. Ohio).